Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now full pipeline small index

Vasomotor Symptoms: full-pipeline trial registry

4 of 9 indexed Vasomotor Symptoms trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Vasomotor Symptoms: 9 US clinical trials tracked, 4 recruiting.

Vasomotor Symptoms is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Bonafide Health, running 2 of these trials.

Enrollment posture brief

Registry condition vasomotor-symptoms

OPEN 4 | RECR 44% | LATE 2 | EARLY 3 | RANK #1916 | SPON 2

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Vasomotor Symptoms (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Vasomotor Symptoms

Vasomotor Symptoms lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vasomotor Symptoms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vasomotor Symptoms is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vasomotor Symptoms research.

    Bonafide Health accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Vasomotor Symptoms enrolment sits around 112 participants.

    Median target enrolment is 112 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.

  4. Vasomotor Symptoms research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 31Phase 41

Open and recent trials

9 total, page 1 of 1

RECRUITING NA 250 participants

JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women

Bonafide Health

NCT07238478

RECRUITING Phase 2 120 participants

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

Tioga Pharmaceuticals

NCT07042516

RECRUITING Phase 2 60 participants

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Shehzad Basaria, M.D.

NCT06957691

RECRUITING NA 24 participants

Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture

Inova Health Care Services

NCT07335224

COMPLETED Phase 3 540 participants

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Wyeth is now a wholly owned subsidiary of Pfizer

NCT00421031

COMPLETED NA 355 participants

MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation

Fred Hutchinson Cancer Center

NCT01178892

COMPLETED NA 112 participants

Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women

Bonafide Health

NCT07408115

COMPLETED Phase 2 105 participants

FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

Fervent Pharmaceuticals

NCT05312567

COMPLETED Phase 4 29 participants

Duloxetine for Menopausal Depression

Massachusetts General Hospital

NCT01117857

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Vasomotor Symptoms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

JDS-HF3.0 Dietary supplement
2 trials
Usual Activity Behavioral
1 trials
FP-101 Drug
1 trials
DVS-233 SR Drug
1 trials
fezolinetant - reference formulation Drug
1 trials
Lifestyle Management Behavioral
1 trials
Acupuncture Other
1 trials
Asimadoline Drug
1 trials

US sites by state

Facility locations filed on Vasomotor Symptoms trials. A trial with sites in several states counts in each.

California 3 trials
New York 2 trials
Massachusetts 2 trials
Indiana 2 trials
Georgia 2 trials
Florida 2 trials
Washington 1 trials
Virginia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vasomotor Symptoms page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Vasomotor Symptoms trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Bonafide Health sponsors the most Vasomotor Symptoms trials on record, review their full trial history before evaluating a specific study. See Bonafide Health's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vasomotor Symptoms condition card totals 9 registered trials; most-linked intervention JDS-HF3.0; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.